SCHEMBL13184081

SCHEMBL13184081

COc1cc(N2CCCCCC2)ccc1I

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.58
▸ LMNA P02545 2/20 0.55
▸ HIF1A Q16665 3/20 0.47
▸ SLC16A3 O15427 2/20 0.47
▸ SLC16A1 P53985 2/20 0.47
▸ MAPT P10636 5/20 0.43
▸ L3MBTL1 Q9Y468 3/20 0.43
▸ NPC1 O15118 3/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ GAA P10253 2/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ PABPC1 P11940 1/20 0.43
▸ GFER P55789 2/20 0.43
▸ SIRT6 Q8N6T7 1/20 0.42
▸ S100B P04271 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24992445 0.85 SIRT6 (0.58) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL28860292 0.84 ALDH1A1 (0.63) ALDH1A1LMNAHIF1ASLC16A3SLC16A1
SCHEMBL12765629 0.83 ADRB1 (0.56) LMNAMAPT
SCHEMBL24992440 0.83 MEN1 (0.54) ALDH1A1LMNAHIF1AMAPTNPC1
SCHEMBL7303075 0.82 ALDH1A1 (0.65) ALDH1A1LMNAHIF1ASLC16A3SLC16A1
SCHEMBL24992438 0.81 NTSR1 (0.43) ALDH1A1LMNAMAPTKDM4E
SCHEMBL12856135 0.81 ALDH1A1 (0.59) ALDH1A1LMNAHIF1ASLC16A3SLC16A1
SCHEMBL12625177 0.79 ALDH1A1 (0.58) ALDH1A1LMNAHIF1ASLC16A3SLC16A1
SCHEMBL807418 0.79 ALDH1A1 (0.58) ALDH1A1LMNAHIF1ASLC16A3SLC16A1
SCHEMBL13682933 0.79 ALDH1A1 (0.58) ALDH1A1LMNAHIF1ASLC16A3SLC16A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8324216-B2 Substituted piperazines CHEMOCENTRYX, INC. (US) 2012-12-04 — — US disclosed
US-20100240618-A1 SUBSTITUTED PIPERAZINES CHEMOCENTRYX, INC. (US) 2010-09-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240618-A1 SUBSTITUTED PIPERAZINES CCR1, CCR3, CCRL2 ALDH1A1 951/4885LMNA 4351/4885HIF1A 1881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback